Hasnyálmirigyrák: vizsgálatok itt: Olaszország
92 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Bologna, Brescia, Milan, Naples, Siena, Verona
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 3. fázisTaking peopleAtebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Bari, Bologna, Florence, Meldola, Milan, Naples, Padova, Pavia, Pesaro, Pisa, Verona
- Életkor
- 18 év and over
- People
- 570 worldwide
- Run by
- Immuneering Corporation
See details and how to joinNCT07562152 · EU 2026-525617-31-00 - 3. fázisTaking peopleStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Where
- Florence, Padova
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07621718 - No phaseTaking peopleFeasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy
- Where
- Milan
- Életkor
- 18 év and over
- People
- 35
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07095621 - 1. fázisTaking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Milan
- Életkor
- 18 év and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Milan, Reggio Emilia, Rome
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Bergamo, Milan, Naples, Perugia, Siena
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 3. fázisTaking peopleA Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Where
- Bergamo, Brescia, Catania, Florence, Foggia, Genoa, Milan, Padova, Parma, Pisa, Ravenna, Reggio Emilia, Rome, Rozzano, Siena, Verona, Vicenza
- Életkor
- 18 év and over
- People
- 614 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07409272 · EU 2025-523684-38-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Aviano, Bologna, Meldola, Milan, Naples, Orbassano to, Palermo, Roma
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 3. fázisTaking peopleA Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma, Rome, Rozzano, Verona
- Életkor
- 18 év and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073 - No phaseTaking peoplePancreatic Cancer Early Detection Consortium
- Where
- Verona
- Életkor
- 18 év to 90 év
- People
- 20 000 worldwide
- Run by
- Arbor Research Collaborative for Health
See details and how to joinNCT04970056 - 1/2. fázisTaking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Milan, Rome
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - 1/2. fázisTaking peopleBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Milan, Naples, Pisa
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Aviano, Milan, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Bergamo, Genova, Naples, Verona
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 3. fázisTaking peopleStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Milan, Naples, Padova, Pisa, Rome, Verona
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07252232 · EU 2025-523495-23-00 - 3. fázisNot yet taking people in OlaszországPhase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Bologna, Florence, Foggia, Meldola, Milan, Modena, Naples, Padova, Pisa, Rome, Rozzano, Tricase, Verona
- Életkor
- 18 év and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00 · EU 2025-524969-24-00 - No phaseNot yet taking people in OlaszországTargeted Nutritional Intervention (HMB, Arginine, Glutamine) in Patients With Pancreatic Cancer
- Where
- Roma
- Életkor
- 18 év and over
- People
- 24
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07883161 - 1/2. fázisTaking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Milan, Pisa, Roma
- Életkor
- 18 év and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - 2/3. fázisNot yet taking people in OlaszországA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Milan, Rozzano, Verona
- Életkor
- 18 év and over
- People
- 194 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-522563-15-00 · EU 2025-522563-15-00 - 1. fázisTaking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Bologna, Candiolo, Naples, Rozzano, Verona
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - 2/3. fázisTaking peopleA Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Ancona, Florence, Foggia, Milan
- Életkor
- 18 év and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00 - 1/2. fázisNot yet taking people in OlaszországSNIPER-LTFU: Long-term follow-up study of patients administered with RR001 in the interventional Parent SNIPER study
- Where
- Modena
- Életkor
- 18 év and over
- People
- 18
- Run by
- Eir Biotherapies S.r.l.
See details and how to join2026-525714-59-00 · EU 2026-525714-59-00 - 3. fázisTaking peopleStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Milan, Padova, Pisa, Rome, Rozzano, Tricase, Verona
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00